Rituximab Treatment Dramatically Reduces Neutralizing Humoral Response to mRNA SARS-COV-2 Vaccines in Patients with Autoimmune Diseases

被引：0
|
作者：
Bitoun, Samuel [1 ]
Henry, Julien [2 ]
Fellous, Christelle Vauloup [3 ]
Seror, Raphaele [4 ]
Mouna, Lina [3 ]
Joly, Candie [5 ]
Desjardins, Delphine [5 ]
Bitu, Marie [5 ]
Le Grand, Roger [6 ]
Afonso, Anne-Marie Roque [3 ]
Mariette, Xavier [7 ]
机构：
[1] Univ Paris Saclay, Hop Bicetre, AP HP, INSERM,UMR 1184,FHU,CARE, Paris, France
[2] Univ Paris Saclay, Hop Bicetre, AP HP, INSERM,UMR 1184,FHU,CARE, Le Plessis Robinson, France
[3] Univ Paris Saclay, Hop Paul Brousse, AP HP, INSERM U1193,Dept Virol, Villejuif, France
[4] Univ Paris Saclay, Hop Bicetre, AP HP, INSERM,UMR 1184,FHU,CARE, Le Kremlin Bicetre, France
[5] Paris Saclay Univ, Inserm, UMR 1184, FHU CARE,CEA, Le Kremlin Bicetre, France
[6] Univ Paris Saclay, UMR1184, IDMIT Dept, Inserm,CEA, Fontenay Aux Roses, France
[7] Univ Paris Saclay, Rheumatol, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0964
引用
收藏
页码：2016 / 2018
页数：3
相关论文
共 50 条
  • [1] Humoral immune response to SARS-CoV-2 vaccines in patients with autoimmune rheumatic diseases
    Maria Corbalan, Paula
    Hernan Tomas-Grau, Rodrigo
    Pera, Mariana
    Ploper, Diego
    Vanesa Espasa, Gabriela
    Ines Cazorla, Silvia
    Lilia Leguizamon, Maria
    Vera Pingitore, Esteban
    Lucia Barbaglia, Ana
    Maldonado-Galdeano, Carolina
    Constanza Bertolaccini, Maria
    Estefania Soliz-Santander, Silvana
    Gonzalez Lucero, Luciana
    Luis Avila, Cesar
    Nieves Chehin, Rosana
    Raul Sueldo, Hector
    Benjamin Socias, Sergio
    Ines Bellomio, Veronica
    ARCHIVES OF MEDICAL RESEARCH, 2025, 56 (03)
  • [2] Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases
    Oliosi, E.
    Flahault, A.
    Charre, C.
    Veyer, D.
    Combier, A.
    Lafont, E.
    Karras, A.
    Mouthon, L.
    Avouac, J.
    Terrier, B.
    Hadjadj, J.
    CLINICAL RHEUMATOLOGY, 2023, 42 (09) : 2485 - 2490
  • [3] Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases
    E. Oliosi
    A. Flahault
    C. Charre
    D. Veyer
    A. Combier
    E. Lafont
    A. Karras
    L. Mouthon
    J. Avouac
    B. Terrier
    J. Hadjadj
    Clinical Rheumatology, 2023, 42 : 2485 - 2490
  • [4] Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
    Barbora Bacova
    Zuzana Kohutova
    Ivana Zubata
    Lubica Gaherova
    Petr Kucera
    Tomas Heizer
    Marcela Mikesova
    Tomas Karel
    Jan Novak
    Clinical and Experimental Medicine, 2023, 23 : 371 - 379
  • [5] Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
    Bacova, Barbora
    Kohutova, Zuzana
    Zubata, Ivana
    Gaherova, Lubica
    Kucera, Petr
    Heizer, Tomas
    Mikesova, Marcela
    Karel, Tomas
    Novak, Jan
    HAEMATOLOGICA, 2022, 107 (12) : 2988 - 2989
  • [6] Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
    Bitzenhofer, Michaela
    Suter-Riniker, Franziska
    Moor, Matthias B.
    Sidler, Daniel
    Horn, Michael P.
    Gschwend, Anna
    Staehelin, Cornelia
    Rauch, Andri
    Helbling, Arthur
    Joerg, Lukas
    PLOS ONE, 2022, 17 (06):
  • [7] Safety and humoral response to mRNA SARS-CoV-2 vaccines in autoimmune neurological disorders: the ANCOVAX study
    Giannoccaro, M.
    Vacchiano, V.
    Leone, M.
    Camilli, F.
    Zenesini, C.
    Panzera, I.
    Balboni, A.
    Tappata, M.
    Borghi, A.
    Salvi, F.
    Lugaresi, A.
    Rinaldi, R.
    Di Felice, G.
    Lodi, V.
    Lazzarotto, T.
    Liguori, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 361 - 361
  • [8] Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study
    Maria Pia Giannoccaro
    Veria Vacchiano
    Marta Leone
    Federico Camilli
    Corrado Zenesini
    Ivan Panzera
    Alice Balboni
    Maria Tappatà
    Annamaria Borghi
    Fabrizio Salvi
    Alessandra Lugaresi
    Rita Rinaldi
    Giulia Di Felice
    Vittorio Lodi
    Tiziana Lazzarotto
    Rocco Liguori
    Journal of Neurology, 2022, 269 : 4000 - 4012
  • [9] Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study
    Giannoccaro, Maria Pia
    Vacchiano, Veria
    Leone, Marta
    Camilli, Federico
    Zenesini, Corrado
    Panzera, Ivan
    Balboni, Alice
    Tappata, Maria
    Borghi, Annamaria
    Salvi, Fabrizio
    Lugaresi, Alessandra
    Rinaldi, Rita
    Di Felice, Giulia
    Lodi, Vittorio
    Lazzarotto, Tiziana
    Liguori, Rocco
    JOURNAL OF NEUROLOGY, 2022, 269 (08) : 4000 - 4012
  • [10] SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases
    Kalin, Tobias
    Passarin, Katia
    Filipowic-Sinnreich, Magdalena
    Semela, David
    Seifert, Tanja
    Sallusto, Federica
    Vergani, Diego
    Cerny, Andreas
    Mieli-Vergani, Giorgina
    Beretta-Piccoli, Benedetta Terziroli
    JOURNAL OF AUTOIMMUNITY, 2024, 149
12345